Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China’s First SSTR4 Agonist Targeting Pain By Investing.com

GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical (TADAWUL:)…

Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb).

CHENGDU, China, Jan. 11, 2025 /PRNewswire/ — Sichuan  Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that…

Elliptic Labs Signs New Expansion License Contract for 20 Smartphone Models By Investing.com

OSLO, Norway–(BUSINESS WIRE)–Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in…

IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors

Exclusive global license outside of Greater China for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug…